QUADRA: A phase 2, open-label, single-arm study to evaluate niraparib in patients (pts) with relapsed ovarian cancer (ROC) who have received ≥3 prior chemotherapy regimens.

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Moore, KN; Secord, AA; Geller, MA; Miller, DS; Cloven, NG; Fleming, GF; Wahner Hendrickson, AE; Azodi, M; DiSilvestro, P; Oza, AM; Cristea, MC; Berek, JS; Chan, JK; Li, Y; Clark, R; Matulonis, UA; Monk, BJ

Published Date

  • May 20, 2018

Published In

Volume / Issue

  • 36 / 15_suppl

Start / End Page

  • 5514 - 5514

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2018.36.15_suppl.5514